Literature DB >> 20207959

A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.

Gregory M Frank1, Sherrie J Divito, Dawn M Maker, Min Xu, Robert L Hendricks.   

Abstract

PURPOSE. Interleukin (IL)-12p40 can couple with IL-12p35 or p19 chains to form the molecules IL-12p70 and IL-23, respectively, which promote T(H)1 cytokine responses. IL-12p35 can bind to EBI3 to form the anti-inflammatory molecule IL-35, but a proinflammatory function of IL-12p35 independent of IL-12p40 has not been described. Here such a function in a mouse model of herpes stromal keratitis (HSK), a CD4(+) T(H)1 cell-dependent corneal inflammation, is demonstrated. METHODS. Corneas of wild-type (WT), IL-12p40(-/-), IL-12p35(-/-), and IL-12p35(-/-)p40(-/-) (double knockout) mice were infected with the RE strain of HSV-1, and HSK was monitored based on corneal opacity, neovascularization, leukocytic infiltrate, and cytokine/chemokine levels. RESULTS. All mouse strains developed moderate HSK by 11 days after infection (dpi). However, from 11 to 21 dpi, HSK progressed in WT and IL-12p40(-/-) mice but regressed in IL-12p35(-/-) and IL-12p35(-/-)p40(-/-) mice. HSK regression was characterized by reductions in neutrophils and CD4(+) T cells and attenuation of blood vessels, which was associated with reduced levels of the chemokines KC (CXCL3), Mip-2 (CXCL2), and MCP-1 (CCL2) and the angiogenic factor vascular endothelial growth factor. CONCLUSIONS. HSK development does not require IL-12p40 and is thus independent of IL-12p70 and IL-23. However, late HSK progression does require a previously unrecognized IL-12p40-independent, proinflammatory function of IL-12p35.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207959      PMCID: PMC2904011          DOI: 10.1167/iovs.09-4368

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice.

Authors:  Yanira Osorio; Steven L Wechsler; Anthony B Nesburn; Homayon Ghiasi
Journal:  Virus Res       Date:  2002-12       Impact factor: 3.303

2.  CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.

Authors:  Susmit Suvas; Ahmet Kursat Azkur; Bum Seok Kim; Uday Kumaraguru; Barry T Rouse
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

3.  Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice.

Authors:  Edward E S Nieuwenhuis; Markus F Neurath; Nadia Corazza; Hideki Iijima; Joanne Trgovcich; Stefan Wirtz; Jonathan Glickman; Dan Bailey; Masaru Yoshida; Peter R Galle; Mitchell Kronenberg; Mark Birkenbach; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice.

Authors:  Khaldun Al-Khatib; Iain L Campbell; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

5.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

6.  IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts.

Authors:  Jeroen Maertzdorf; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

7.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

9.  IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1.

Authors:  Tonya D Russell; Qingyun Yan; Guangshun Fan; Anthony P Khalifah; D Keith Bishop; Steven L Brody; Michael J Walter
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

10.  CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Authors:  Kaustuv Banerjee; Partha S Biswas; Bumseok Kim; Sujin Lee; Barry T Rouse
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

View more
  12 in total

1.  Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages.

Authors:  Alessandra Fraternale; Giuditta Fiorella Schiavano; Maria Filomena Paoletti; Linda Palma; Mauro Magnani; Giorgio Brandi
Journal:  Med Microbiol Immunol       Date:  2014-03-29       Impact factor: 3.402

Review 2.  Interleukin-35 in immune-related diseases: protection or destruction.

Authors:  Junfeng Zhang; Yunsheng Zhang; Qingpeng Wang; Chunlei Li; Hongxin Deng; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

3.  Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia.

Authors:  Susanne Himmelein; Anthony J St Leger; Jared E Knickelbein; Alexander Rowe; Michael L Freeman; Robert L Hendricks
Journal:  Herpesviridae       Date:  2011-03-15

Review 4.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

5.  Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.

Authors:  Kristine-Ann G Buela; Robert L Hendricks
Journal:  J Immunol       Date:  2014-11-24       Impact factor: 5.422

6.  Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?

Authors:  Smitha J Sasindran; Jordi B Torrelles
Journal:  Front Microbiol       Date:  2011-01-26       Impact factor: 5.640

7.  Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

Authors:  Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 8.  Immunological aspects of acute and recurrent herpes simplex keratitis.

Authors:  Jacek Rolinski; Iwona Hus
Journal:  J Immunol Res       Date:  2014-09-07       Impact factor: 4.818

9.  Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.

Authors:  Chyan-Jang Lee; Oleksiy Buznyk; Lucia Kuffova; Vijayalakshmi Rajendran; John V Forrester; Jaywant Phopase; Mohammad M Islam; Mårten Skog; Jenny Ahlqvist; May Griffith
Journal:  Transl Vis Sci Technol       Date:  2014-05-29       Impact factor: 3.283

Review 10.  IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.

Authors:  Kewei Liu; Ai Huang; Jun Nie; Jun Tan; Shijie Xing; Yue Qu; Ke Jiang
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.